Powered by OpenAIRE graph
Found an issue? Give us feedback
downloadFull-Text
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ https://doi.org/10.1...arrow_drop_down
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
https://doi.org/10.11406/rinke...
Article . 2014 . Peer-reviewed
Full-Text: https://www.jstage.jst.go.jp/article/rinketsu/55/10/55_1817/_pdf
Data sources: Japan Link Center
https://pubmed.ncbi.nlm.nih.go...
Article . 2015
Data sources: Europe PubMed Central
 View all 2 versions
Claim

[Treatment for acute promyelocytic leukemia].

descriptionPublicationkeyboard_double_arrow_right Article 01 Jan 2014 Japanese Publisher:The Japanese Society of HematologyJournal:[Rinsho ketsueki] The Japanese journal of clinical hematology, volume 55 (issn: 0485-1439, Copyright policy )
Authors: FUJITA, Hiroyuki;

pmid: 25297745

[Treatment for acute promyelocytic leukemia].

No summary information available
Keywords

Receptors, Retinoic Acid, All-<i>trans</i> retinoic acid, Promyelocytic Leukemia Protein, Benzoates, Arsenicals, Maintenance Chemotherapy, Arsenic Trioxide, Leukemia, Promyelocytic, Acute, Acute promyelocytic leukemia, Arsenic trioxide, Recurrence, Antineoplastic Combined Chemotherapy Protocols, Humans, Molecular Targeted Therapy, Retinoic Acid Receptor alpha, Remission Induction, Nuclear Proteins, Oxides, Induction Chemotherapy, Disseminated Intravascular Coagulation, Consolidation Chemotherapy, Tamibarotene, Clinical Trials, Phase III as Topic, Gene Fusion

  • BIP!
    Impact byBIP!
    selected citations
    These citations are derived from selected sources.
    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    		 0
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    		 Average
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    		 Average
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    		 Average
Powered by OpenAIRE graph
Found an issue? Give us feedback
selected citations
These citations are derived from selected sources.
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Citations provided by BIP!
popularity
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
BIP!Popularity provided by BIP!
influence
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Influence provided by BIP!
impulse
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
BIP!Impulse provided by BIP!
0
Average
Average
Average
Related to Research communities
Cancer Research